How should chimerism be decoded?1
暂无分享,去创建一个
E. Robinet | P. Tiberghien | C. Ferrand | P. Saas | A. Martens | S. Perruche | É. Robinet
[1] A. Hagenbeek,et al. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat. , 2004, Experimental hematology.
[2] M. Bernard,et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. , 2002, Blood.
[3] I. Lossos,et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. , 2002, Blood.
[4] A. Barrett,et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. , 2001, Blood.
[5] C. Contag,et al. Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 , 2001, The Journal of Immunology.
[6] M. Sykes,et al. Mixed chimerism and transplant tolerance. , 2001, Immunity.
[7] Craig W. Reynolds,et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. , 2001, Blood.
[8] A. Zander,et al. CD34 splice variant: an attractive marker for selection of gene-modified cells. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] T. Barbui,et al. Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies. , 2000, Human gene therapy.
[10] N. Young,et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. , 1999, Blood.
[11] M. Shlomchik,et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.
[12] M. Florek,et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection , 1999, Bone Marrow Transplantation.
[13] T. Starzl,et al. Antigen localization and migration in immunity and tolerance. , 1998, The New England journal of medicine.
[14] K. Okasha,et al. Analysis of the relationship between chimerism and the allgeneic humoral response. , 1998, Transplantation.
[15] G. Szot,et al. Separate regulation of peripheral hematopoietic and thymic engraftment. , 1998, Experimental hematology.
[16] S. Jimenez,et al. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. , 1998, The New England journal of medicine.
[17] H. Schlitt,et al. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. , 1994, The New England journal of medicine.
[18] C. Ricordi,et al. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. , 1993, Trends in pharmacological sciences.
[19] B. Budowle,et al. Population genetics and forensic efficiency data of 4 AMPFLP's , 1992, International Journal of Legal Medicine.
[20] S. Orkin,et al. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms. , 1985, The Journal of clinical investigation.
[21] P. Matzinger,et al. Immunity or tolerance: Opposite outcomes of microchimerism from skin grafts , 2001, Nature Medicine.
[22] S. Riddell,et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells , 1999, Nature Medicine.
[23] C. Bordignon,et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. , 1994, Blood.